Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)

Clinical trial NCT07089784 · COMPLETED

Trial details

NCT number: NCT07089784
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2025-09-22
Primary completion: 2026-05-04
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.